Press Releases Events & Presentations Press Releases Year None2019201820172016201520142013201220112010 Dec 16, 2019 Assembly Biosciences Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares View HTML PDF Version Dec 12, 2019 Assembly Biosciences Announces Pricing of $125 Million Public Offering View HTML PDF Version Dec 11, 2019 Assembly Biosciences Announces Proposed Public Offering of Common Stock View HTML PDF Version Dec 06, 2019 Assembly Biosciences Announces Plenary Lecture at HEP DART 2019 View HTML PDF Version Nov 18, 2019 Assembly Biosciences Announces Presentation at Jefferies London Healthcare Conference View HTML PDF Version Nov 11, 2019 Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019 View HTML PDF Version Nov 07, 2019 Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Nov 07, 2019 Assembly Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights View HTML PDF Version Nov 07, 2019 Assembly Biosciences Appoints Luisa Stamm, MD, PhD, as Chief Medical Officer View HTML PDF Version Oct 28, 2019 Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
Press Releases Year None2019201820172016201520142013201220112010 Dec 16, 2019 Assembly Biosciences Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares View HTML PDF Version Dec 12, 2019 Assembly Biosciences Announces Pricing of $125 Million Public Offering View HTML PDF Version Dec 11, 2019 Assembly Biosciences Announces Proposed Public Offering of Common Stock View HTML PDF Version Dec 06, 2019 Assembly Biosciences Announces Plenary Lecture at HEP DART 2019 View HTML PDF Version Nov 18, 2019 Assembly Biosciences Announces Presentation at Jefferies London Healthcare Conference View HTML PDF Version Nov 11, 2019 Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019 View HTML PDF Version Nov 07, 2019 Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Nov 07, 2019 Assembly Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights View HTML PDF Version Nov 07, 2019 Assembly Biosciences Appoints Luisa Stamm, MD, PhD, as Chief Medical Officer View HTML PDF Version Oct 28, 2019 Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
